Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx Group (MDXG) Net Margin: 2011-2025

Historic Net Margin for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to 14.73%.

  • Mimedx Group's Net Margin rose 535.00% to 14.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.38%, marking a year-over-year decrease of 1278.00%. This contributed to the annual value of 12.04% for FY2024, which is 532.00% down from last year.
  • Latest data reveals that Mimedx Group reported Net Margin of 14.73% as of Q3 2025, which was up 50.98% from 9.75% recorded in Q2 2025.
  • Mimedx Group's Net Margin's 5-year high stood at 51.63% during Q4 2023, with a 5-year trough of -20.50% in Q1 2022.
  • Over the past 3 years, Mimedx Group's median Net Margin value was 9.37% (recorded in 2024), while the average stood at 13.20%.
  • Its Net Margin has fluctuated over the past 5 years, first skyrocketed by 7,464bps in 2021, then slumped by 4,362bps in 2024.
  • Over the past 5 years, Mimedx Group's Net Margin (Quarterly) stood at -2.75% in 2021, then surged by 1,369bps to 10.94% in 2022, then surged by 4,069bps to 51.63% in 2023, then tumbled by 4,362bps to 8.01% in 2024, then surged by 535bps to 14.73% in 2025.
  • Its last three reported values are 14.73% in Q3 2025, 9.75% for Q2 2025, and 7.96% during Q1 2025.